Rare diseases
Investigational molecules
Locations
Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer
AustriaStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
BulgariaStudy of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment
BelgiumStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
FranceStudy on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma
AustriaStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)
AustriaStudy of Tislelizumab, Gemcitabine, and Cisplatin for Patients with Relapsed or Refractory Hodgkin Lymphoma in Metabolic Complete Remission
BelgiumStudy of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
DenmarkStudy Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer
FranceStudy on the Effects of Volrustomig and Drug Combination for Patients with Advanced Hepatobiliary Cancer
ItalyStudy Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma
BelgiumStudy on SOT102 for Patients with Advanced Gastric and Pancreatic Cancer, Alone or with Drug Combination
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
